ACELYRIN(SLRN) - 2024 Q2 - Earnings Call Presentation

| --- | --- | --- | |----------------------------|-------|-------| | | | | | | | | | | | | | | | | | Accelerating Medicines to | | | | Transform Patients' Lives | | | Q2 2024 Financial Results August 13, 2024 Forward Looking Statements & Disclaimer This presentation contains statements that are not of historical facts, considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward- ...